| GTIN | 7680572950120 |
| Bezeichnung | EQUASYM XR Ret Kaps 20 mg 30 Stk |
| ATC-Code | N06BA04 |
| Firma | Takeda Pharma AG |
| erste Meldung | 23.07.2024 |
| erste Meldung durch | Firma |
| erste Info durch die Firma | |
| Art der Info durch die Firma | Info Brief/Mail ohne Alternativvorschlag |
| voraussichtliche Dauer | Dauer unbestimmt |
| Status des Engpasses | 1 aktuell keine Lieferungen |
| ca. Datum der Wiederherstellung der Lieferfähigkeit | Distribution interruption |
| Bemerkungen | We regret to inform you that we expect an interruption of operations with the product Equasym® and that we expect to be available from approx. will no longer be able to meet demand by the end of 2024. Due to the very low demand for a long time and the availability of several equivalent alternative medicines, we are therefore considering cancelling the approval of Equasym® in Switzerland. Therefore, please consider switching all patients to alternative products at an early stage. |
| Datum der letzten Mutation | 23.07.2024 |